A multi-generational family gathers in a brightly lit kitchen to prepare breast fast.

RESOURCES = BETTER OUTCOMES

Genetic Testing

Genetic testing may be an option for those who want more information about their cancer risk based on their family history or race/ethnicity.

Genetic testing involves looking for changes in a person’s genes, called mutations (or variants), that impact risk and could be found before any other signs of a disease. These mutations are inherited from a parent and carry different risks for cancer based on the specific mutation. Genetic testing can be performed by testing a person’s blood or saliva to identify whether they have inherited a genetic mutation in one of these genes.

There are many types of mutations that can be identified through genetic testing and are linked to hereditary cancer syndromes. Two of the most well-known genetic mutations in cancer are found in the BRCA1 and BRCA2 genes. Mutations found in these genes can lead to an increased risk of breast and ovarian cancers, or less commonly, of prostate and pancreatic cancers. There are additional gene mutations that increase risk for breast, colorectal or prostate cancers (see below for more info on genetic mutations and these cancer types).

Knowing your family health history is a good place to start. Use these tools to gather your family health history and discuss it with your health care provider.

NOTE: This information refers to predictive genetic testing only, which is different from tumor profiling (also known as genomic, biomarker or molecular profiling). Tumor profiling is done after a cancer diagnosis to determine mutations that may affect how the patient responds to certain treatments.

Most cancers are not hereditary—and not everyone with a genetic mutation goes on to develop cancer.

Even if you test negative for these mutations, you can still develop cancer (like anyone!). Most people who have cancer do not have a genetic mutation—only 5%-10% of cancer cases are caused by hereditary gene mutations. Take care to reduce your cancer risk and get the routine cancer screenings you need for better outcomes.

Ways to prevent cancer

Frequently Asked Questions

Everything you need to know about genetic testing for cancer risk

If you are adopted or estranged from your family

If you are adopted or estranged from your family, you might have limited or no knowledge of your family history. Talk to your genetic counselor or health care provider about any family health history you are aware of and your race/ethnicity to see if genetic testing makes sense for you. You should also always inform your health care provider if you are adopted.

Talking to your family

Gene mutations are hereditary and some of your relatives likely share similar or identical risk factors. Please discuss this topic with your family and help make them aware of their options, but understand if they make a different decision than you about genetic testing. It is a decision between each person and their health care providers and genetic counselors. Everyone has the right not to know about their genetic mutations.

Breast Cancer

Those assigned female at birth who test positive for BRCA1, BRCA2, PALB2 or several other gene mutations are at increased risk for breast or ovarian cancer. Those assigned male at birth who have BRCA2 mutations have an increased risk of breast cancer, and the same is true to a lesser degree for BRCA1 mutations. (Those assigned male at birth with BRCA1 or BRCA2 mutations are also at increased risk for prostate and pancreatic cancers.) BRCA mutations occur in all races and ethnicities, but one in 40 people of Ashkenazi Jewish descent has a mutation in the BRCA gene.

Colorectal Cancer

Those with a personal or family history of colorectal cancer or colon polyps, or a family history of Lynch syndrome (also called hereditary non-polyposis colorectal cancer) or familial adenomatous polyposis (FAP), are at increased risk for colorectal cancer. Genetic mutations associated with Lynch syndrome include MLH1, MSH2, MSH6, PMS2, EPCAM and those associated with FAP include APC.

Prostate Cancer

Those who were assigned male at birth who test positive for BRCA1, BRCA2, HOXB13 or several other gene mutations are at increased risk for prostate cancer. (Those who were assigned male at birth with BRCA1 or BRCA2 mutations are also at increased risk for breast and pancreatic cancers.) BRCA mutations occur in all races and ethnicities, but one in 40 of those of Ashkenazi Jewish descent has a mutation in the BRCA gene.